Get the Stockscreener App
2.50
8.52%
-0.20
After Hours:
2.50
Creative Medical Technology Holdings Inc Stock (CELZ) Forecast
The Creative Medical Technology Holdings Inc (CELZ) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.912, representing a +56.48% increase from the current price of $2.50. The highest analyst price target is $4.137, and the lowest is $3.687.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CELZ Price Target
Average 4.5517
(+82.07% Upside)
Is Creative Medical Technology Holdings Inc (CELZ) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 35.12 | Neutral |
| STOCH(9,6) | 9.3445 | Buy |
| STOCHRSI(14) | 4.7265 | Buy |
| MACD(12,26) | -0.3006 | Sell |
| ADX(14) | 23.73 | Neutral |
| William %R | -99.14 | Buy |
| CCI(14) | -86.42 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.849
Sell
|
2.8934
Sell
|
| MA20 |
3.3415
Sell
|
3.1827
Sell
|
| MA50 |
3.4356
Sell
|
3.4065
Sell
|
| MA100 |
3.4486
Sell
|
3.5705
Sell
|
| MA200 |
4.0414
Sell
|
3.8683
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CELZ could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 11 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on CELZ, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 35.12 indicates that CELZ is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 9.3445 indicates that CELZ is oversold. This indicates that CELZ price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 4.7265 indicates that CELZ is oversold. This suggests that CELZ price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 23.73 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -86.42 indicates that CELZ is still oversold but not to an extreme extent.
Long-term CELZ price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Creative Medical Technology Holdings Inc financial reports and earnings history, Creative Medical Technology Holdings Inc (CELZ) stock could reach $10.37 by 2030, $34.59 by 2040 and $36.39 by 2050. See the projected annual prices until 2050 of the Creative Medical Technology Holdings Inc stock below:
- Creative Medical Technology Holdings Inc (CELZ) is expected to reach an average price of $24.75 in 2035, with a high prediction of $25.07 and a low estimate of $24.44. This indicates an $889.95% rise from the last recorded price of $2.50.
- Creative Medical Technology Holdings Inc (CELZ) stock is projected to chart a bullish course in 2040, with an average price target of $32.94, representing an $1,218% surge from its current level. The forecast ranges from a conservative $31.85 to a sky-high $34.59.
- Our analysts predict Creative Medical Technology Holdings Inc (CELZ) to jump 1,242% by 2045, soaring from $32.82 to an average price of $33.54, potentially reaching $34.02. While $32.82 is the low estimate, the potential upside is significant.
- Creative Medical Technology Holdings Inc (CELZ) stock is expected to climb by 2050, reaching an average of $36.37, a $1,355% jump from its current level. However, a wide range of estimates exists, with high and low targets of $36.39 and $35.76, respectively, highlighting the market's uncertainty.
Creative Medical Technology Holdings Inc Stock (CELZ) Year by Year Forecast
Creative Medical Technology Holdings Inc Stock (CELZ) Price Forecast for 2024
Our forecast for CELZ stock price in 2024 now indicates an average price target of $6.9841 with a high forecast of $10.28 and a low forecast of $3.687. The average prediction reflects an increase of +179.36% from the last recorded price of $2.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $3.8881 | $3.687 | $4.137 | +55.53% |
Creative Medical Technology Holdings Inc Stock (CELZ) Price Forecast for 2025
Creative Medical Technology Holdings Inc Stock (CELZ) is expected to reach an average price of $4.5825 in 2025, with a high prediction of $5.4165 and a low estimate of $3.7485. This indicates an +83.30% rise from the last recorded price of $2.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $3.9918 | $3.7485 | $4.0501 | +59.67% |
| February, 2025 | $4.0297 | $3.953 | $4.0659 | +61.19% |
| March, 2025 | $3.9609 | $3.9239 | $4.1225 | +58.44% |
| April, 2025 | $3.9232 | $3.8249 | $4.0188 | +56.93% |
| May, 2025 | $3.9968 | $3.9357 | $4.2361 | +59.87% |
| June, 2025 | $4.0408 | $3.9924 | $4.1034 | +61.63% |
| July, 2025 | $4.2277 | $4.0589 | $4.2512 | +69.11% |
| August, 2025 | $4.3842 | $4.2309 | $4.4321 | +75.37% |
| September, 2025 | $4.5137 | $4.3752 | $5.3025 | +80.55% |
| October, 2025 | $4.5457 | $4.4559 | $4.6345 | +81.83% |
| November, 2025 | $4.7757 | $4.5265 | $5.4165 | +91.03% |
| December, 2025 | $4.7994 | $4.7285 | $4.9075 | +91.97% |
Creative Medical Technology Holdings Inc Stock (CELZ) Price Forecast for 2026
The predicted value for Creative Medical Technology Holdings Inc (CELZ) in 2026 is set at an average of $10.07. Estimates vary from a peak of $15.47 to a trough of $4.6775, indicating an +302.93% surge from the present price of $2.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $9.1909 | $4.6775 | $11.01 | +267.63% |
| February, 2026 | $10.16 | $8.6013 | $10.25 | +306.50% |
| March, 2026 | $9.644 | $9.367 | $11.16 | +285.76% |
| April, 2026 | $9.316 | $8.7148 | $9.7844 | +272.64% |
| May, 2026 | $9.6576 | $9.2977 | $11.61 | +286.30% |
| June, 2026 | $9.1292 | $8.9692 | $9.838 | +265.17% |
| July, 2026 | $9.2912 | $9.00 | $9.548 | +271.65% |
| August, 2026 | $9.6528 | $9.2228 | $11.52 | +286.11% |
| September, 2026 | $9.3248 | $9.2044 | $9.8432 | +272.99% |
| October, 2026 | $9.3357 | $9.2752 | $9.4663 | +273.43% |
| November, 2026 | $11.44 | $9.0568 | $15.47 | +357.52% |
| December, 2026 | $10.50 | $10.01 | $11.95 | +320.00% |
Creative Medical Technology Holdings Inc Stock (CELZ) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Creative Medical Technology Holdings Inc (CELZ) is $8.8024, with a high forecast of $10.93 and a low forecast of $6.678. This indicates an +252.10% increase from the last price of $2.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $10.28 | $9.6288 | $10.93 | +311.11% |
| February, 2027 | $8.2824 | $6.7708 | $8.9524 | +231.30% |
| March, 2027 | $7.0764 | $7.0549 | $8.7249 | +183.05% |
| April, 2027 | $7.2596 | $6.678 | $7.688 | +190.38% |
| May, 2027 | $9.0827 | $6.8412 | $9.5027 | +263.31% |
| June, 2027 | $7.9967 | $7.8067 | $10.79 | +219.87% |
| July, 2027 | $6.9899 | $6.9094 | $8.0975 | +179.60% |
| August, 2027 | $6.9812 | $6.9107 | $7.1023 | +179.25% |
| September, 2027 | $6.962 | $6.7739 | $7.2239 | +178.48% |
| October, 2027 | $7.242 | $6.9669 | $7.3003 | +189.68% |
| November, 2027 | $7.3615 | $7.244 | $7.3835 | +194.46% |
| December, 2027 | $7.3074 | $7.2978 | $7.5275 | +192.30% |
Creative Medical Technology Holdings Inc Stock (CELZ) Price Forecast for 2028
In 2028, Creative Medical Technology Holdings Inc (CELZ) is projected to reach an average price of $11.45, with a high projection of $15.58 and a low estimate of $7.3198. This indicates an +357.91% rise from the last price of $2.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $7.4385 | $7.3198 | $7.5022 | +197.54% |
| February, 2028 | $7.5937 | $7.4714 | $7.7922 | +203.75% |
| March, 2028 | $7.7875 | $7.6097 | $7.9178 | +211.50% |
| April, 2028 | $8.0082 | $7.7847 | $8.0317 | +220.33% |
| May, 2028 | $8.6249 | $8.0318 | $9.185 | +244.99% |
| June, 2028 | $8.5362 | $8.4424 | $8.7258 | +241.45% |
| July, 2028 | $8.5913 | $8.4608 | $8.6413 | +243.65% |
| August, 2028 | $8.9353 | $8.6021 | $9.5029 | +257.41% |
| September, 2028 | $9.0286 | $8.9169 | $9.0959 | +261.14% |
| October, 2028 | $13.50 | $8.9475 | $15.30 | +440.07% |
| November, 2028 | $14.44 | $12.93 | $15.58 | +477.43% |
| December, 2028 | $13.51 | $13.30 | $14.97 | +440.35% |
Creative Medical Technology Holdings Inc Stock (CELZ) Price Forecast for 2029
The 2029 price forecast for Creative Medical Technology Holdings Inc Stock (CELZ) is $14.96 on average, with a high prediction of $20.66 and a low estimate of $9.2662. This represents an +498.47% increase from the previous price of $2.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $14.57 | $13.23 | $16.20 | +482.91% |
| February, 2029 | $14.40 | $13.96 | $14.87 | +475.84% |
| March, 2029 | $14.17 | $13.71 | $14.48 | +466.77% |
| April, 2029 | $14.13 | $13.78 | $14.37 | +465.30% |
| May, 2029 | $14.50 | $14.09 | $16.45 | +479.86% |
| June, 2029 | $14.35 | $14.21 | $14.71 | +473.98% |
| July, 2029 | $14.44 | $14.32 | $14.57 | +477.68% |
| August, 2029 | $15.78 | $14.18 | $20.66 | +531.07% |
| September, 2029 | $15.79 | $15.37 | $16.43 | +531.60% |
| October, 2029 | $9.525 | $9.425 | $16.24 | +281.00% |
| November, 2029 | $10.01 | $9.2662 | $11.49 | +300.39% |
| December, 2029 | $9.7146 | $9.6931 | $10.53 | +288.58% |
Creative Medical Technology Holdings Inc Stock (CELZ) Price Forecast for 2030
Creative Medical Technology Holdings Inc Stock (CELZ) is expected to reach an average price of $11.48 in 2030, with a high forecast of $13.61 and a low forecast of $9.357. This signifies an +359.35% surge from the last price of $2.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $9.8905 | $9.357 | $10.37 | +295.62% |
| February, 2030 | $12.37 | $9.6017 | $13.61 | +394.61% |
| March, 2030 | $10.90 | $10.71 | $12.74 | +336.00% |
| April, 2030 | $9.9749 | $9.8944 | $11.02 | +299.00% |
| May, 2030 | $9.8819 | $9.8609 | $10.31 | +295.27% |
| June, 2030 | $10.13 | $9.913 | $10.33 | +305.22% |
| July, 2030 | $10.57 | $10.16 | $10.59 | +322.96% |
| August, 2030 | $10.74 | $10.53 | $10.76 | +329.68% |
| September, 2030 | $10.74 | $10.73 | $10.94 | +329.65% |
| October, 2030 | $11.04 | $10.80 | $11.05 | +341.49% |
| November, 2030 | $11.26 | $11.05 | $11.35 | +350.48% |
| December, 2030 | $11.49 | $11.30 | $11.62 | +359.46% |
4.27%
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):